What is it about?
Enterococcus gallinarum and Enterococcus casseliflavus/flavescens are enterococci intrinsically resistant to vancomycin. Along with their distinguishing vancomycin resistance, due to a chromosomally-encoded VanC operon, their additional intrinsic resistance to many antibiotics other than glycopeptides limits the therapeutic choices. We propose therapeutic algorithms on bloodstream infections, endocarditis, central nervous system infections, endophthalmitis and urinary tract infections
Featured Image
Photo by Finn Mund on Unsplash
Why is it important?
It provides therapeutic algorithms for non-faecium non-faecalis VRE infections
Read the Original
This page is a summary of: Clinical management of non- faecium non- faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens, Journal of Infection and Chemotherapy, April 2018, Elsevier,
DOI: 10.1016/j.jiac.2018.01.001.
You can read the full text:
Contributors
The following have contributed to this page
